These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1078826)

  • 1. Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor.
    Levin AS; Byers VS; Fudenberg HH; Wybran J; Hackett AJ; Johnston JO; Spitler LE
    J Clin Invest; 1975 Mar; 55(3):487-99. PubMed ID: 1078826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer factor therapy in osteogenic sarcoma.
    Levin AS; Byers VS; Fudenberg HH; Wybran J; Hackett AJ; Johnston JO
    Trans Assoc Am Physicians; 1974; 87():153-8. PubMed ID: 4549141
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor-specific cell-mediated immunity in household contacts of cancer patients.
    Byers VS; Levin AS; Hackett AJ; Fudenberg HH
    J Clin Invest; 1975 Mar; 55(3):500-13. PubMed ID: 1078827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disapperance of osteogenic sarcoma after irradiation: immunologic observations.
    Urtasun RC; Connachie PR
    J Can Assoc Radiol; 1976 Jun; 27(2):80-3. PubMed ID: 1066352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant presence of tumor-specific cytotoxic and inhibitor lymphocytes in patients with osteogenic sarcoma.
    Yu A; Watts H; Jaffe N; Parkman R
    N Engl J Med; 1977 Jul; 297(3):121-7. PubMed ID: 325412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of cytotoxic reactivity to cultured normal skin fibroblasts in sera from normal and sarcoma-bearing patients.
    Catapano MS; Brown JM; Rosenberg SA
    Cancer Res; 1980 Apr; 40(4):979-83. PubMed ID: 6928402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
    Delirezh N; Moazzeni SM; Shokri F; Shokrgozar MA; Atri M; Kokhaei P
    Cell Immunol; 2009; 257(1-2):23-31. PubMed ID: 19306994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
    J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of bone tumors in conjunction with microwave-induced hyperthermia and adjuvant immunotherapy. A preliminary report.
    Fan Q; Ma B; Guo A; Li Y; Ye J; Zhou Y; Qiu X
    Chin Med J (Engl); 1996 Jun; 109(6):425-31. PubMed ID: 9206073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal studies of cellular immunity of patients with osteogenic sarcoma during chemoimmunotherapy.
    Sears HF; Simon R; Rosenberg SA
    Cancer Treat Rep; 1980; 64(4-5):589-97. PubMed ID: 6933004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosette-forming cells, immunologic deficiency diseases and transfer factor.
    Wybran J; Levin AS; Spitler LE; Fudenberg HH
    N Engl J Med; 1973 Apr; 288(14):710-3. PubMed ID: 4540063
    [No Abstract]   [Full Text] [Related]  

  • 12. The immunological basis of tumor rejection: the absolute dependence of the effector arm on sensitized T cells after chemoimmunotherapy of a murine sarcoma.
    Evans R; Duffy T
    J Immunol; 1985 Jun; 134(6):4255-60. PubMed ID: 3872913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated in vivo B7-1 gene transfer induces anti-tumor immunity against pre-established primary tumor and pulmonary metastasis of rat osteosarcoma.
    Tsuji H; Kawaguchi S; Wada T; Nagoya S; Inobe M; Yamashita T; Ishii S; Uede T
    Cancer Gene Ther; 2002 Sep; 9(9):747-55. PubMed ID: 12189524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immunity in human osteogenic sarcoma.
    Gangal SG; Agashe SS; Nair PN; Rao RS
    Indian J Cancer; 1973 Sep; 10(3):295-301. PubMed ID: 4522531
    [No Abstract]   [Full Text] [Related]  

  • 15. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K
    Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of radiotherapy on lymphocyte cytotoxicity in vitro.
    Wasserman J; Melén B; Blomgren H; Glas U; Perlmann P
    Clin Exp Immunol; 1975 Nov; 22(2):230-9. PubMed ID: 1082400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytes.
    Nagoshi M; Goedegebuure PS; Burger UL; Sadanaga N; Chang MP; Eberlein TJ
    J Immunol; 1998 Jan; 160(1):334-44. PubMed ID: 9551989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical observations on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitro.
    Chang AE; Yoshizawa H; Sakai K; Cameron MJ; Sondak VK; Shu S
    Cancer Res; 1993 Mar; 53(5):1043-50. PubMed ID: 8439951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell mediated immunity in human osteogenic sarcoma.
    Agashe SS; Nair PN; Rao RS; Gangal SG
    Indian J Cancer; 1975 Mar; 12(1):61-6. PubMed ID: 1058832
    [No Abstract]   [Full Text] [Related]  

  • 20. GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia.
    Turin I; Pedrazzoli P; Tullio C; Montini E; La Grotteria MC; Schiavo R; Perotti C; Locatelli F; Carretto E; Maccario R; Siena S; Montagna D
    Cytotherapy; 2007; 9(5):499-507. PubMed ID: 17786611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.